Unravel Biosciences

Medford, MA · Founded 2021 · Privately Held (backing)

Developer of an artificial intelligence-driven systems biology platform designed to discover and clinically validate therapeutic targets for complex diseases. Unravel Biosciences is based in Medford, MA and was founded in 2021. It was valued at $18 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $4.5 million across 2 recorded rounds; the latest was a $500,000 seed round in Feb 2023.

PMV mark · valuation
$18.0M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$4.5M
Last round
Seed Round
Feb 2023

Who backs Unravel Biosciences?

12 investors
InvestorType
Creative Destruction LabOther
BoxOne VenturesOther
Solari CapitalVenture capital
Harvard UniversityOther
Bacchus Venture Capital—
Venture Development Center (Massachusetts)—
Good VenturesOther
Beresford Ventures—
KdT Ventures—
MassCONNECT—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Unravel Biosciences investors

12 investors are on record for Unravel Biosciences, including Creative Destruction Lab, BoxOne Ventures, Solari Capital and Harvard University. The seed round in Feb 2023 drew 4 investors.

Free account
More of Unravel Biosciences with a free account
  • ·The complete investor list: 12 names
  • ·Watch Unravel Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Unravel Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View